Free public records show Unravel Biosciences, Inc. in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Unravel Biosciences, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by Unravel Biosciences, Inc., of 2 in all
Source: ClinicalTrials.gov, Studies with Unravel Biosciences, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Markets we cover where free public records show Unravel Biosciences, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Unravel Biosciences, Inc. is in.
Stories on the topics Unravel Biosciences, Inc. works in.
Behind every insurance claim is a standard electronic message. The CAQH Index says $20 billion a year could…
Read
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
ReadSearch all reports for Unravel Biosciences, Inc. All companies